Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             48 results found
no title author magazine year volume issue page(s) type
1 A clinical study of MER-29 in patients with angina pectoris Halperin, Meyer H.
 1960
 2 6 p. 631-636
6 p.
 article
2 Aortic subvalvular stenosis. Surgical treatment 1960
 2 6 p. 721-
1 p.
 article
3 Aortopulmonary septal defect 1960
 2 6 p. 721-
1 p.
 article
4 Approach to the interpretation of complex arrhythmias Langendore, Richard
 1960
 2 6 p. 706-719
14 p.
 article
5 A study of MER-29 in experimental animals Portman, O.W.
 1960
 2 6 p. 531-535
5 p.
 article
6 Basic research leading to MER-29 Palopoli, Frank P.
 1960
 2 6 p. 489-491
3 p.
 article
7 Clinical evaluation of MER-29 in the treatment of hypercholesterolemia associated with atherosclerosis Leckert, John T.
 1960
 2 6 p. 571-575
5 p.
 article
8 Clinical experience with MER-29, an inhibitor of cholesterol synthesis Estes, J. Earle
 1960
 2 6 p. 564-570
7 p.
 article
9 Clinical features and surgical treatment of fity patients with severe aortic stenosis 1960
 2 6 p. 720-
1 p.
 article
10 Clinical observations on the effects of MER-29 Kountz, William B.
 1960
 2 6 p. 541-543
3 p.
 article
11 Clinical pertusion technique 1960
 2 6 p. 721-
1 p.
 article
12 Current status of theories of mechanisms of atrial tachycardias, flutter and fibrillation Katz, Louis N.
 1960
 2 6 p. 650-662
13 p.
 article
13 Current status of treatment of paroxysmal atrial tachycardia Orgain, Edward S.
 1960
 2 6 p. 663-676
14 p.
 article
14 Editorial note 1960
 2 6 p. 486-
1 p.
 article
15 Effect of MER-29 on serum cholesterol and blood clotting mechanisms: A plan of study and preliminary findings. I McDevitt, Ellen
 1960
 2 6 p. 553-554
2 p.
 article
16 Effect of MER-29 on serum cholesterol and blood clotting mechanisms: A plan of study and preliminary findings. II Todd, Margaret E.
 1960
 2 6 p. 555-562
8 p.
 article
17 Effect of MER-29 on the pain experience and the electrocardiographic response to standard exercise in patients with coronary artery disease Russek, Henry I.
 1960
 2 6 p. 578-585
8 p.
 article
18 Effect of MER-29 (Triparanol) on serum cholesterol, cholesterol esters and liver enzymes Ruskin, Arthur
 1960
 2 6 p. 624-630
7 p.
 article
19 Effects of MER-29 on sterol concentration in rat tissues and on cholesterol biosynthesis in vivo and in vitro from mevalonic acid-2-C14 Gould, R. Gordon
 1960
 2 6 p. 492-503
12 p.
 article
20 Effects of MER-29 on the intermediary metabolism of cholesterol Frantz Jr., Ivan D.
 1960
 2 6 p. 511-518
8 p.
 article
21 Evaluation of the administration of MER-29 to a group of institutionalized patients at the St. Louis Chronic Hospital; a preliminary report Toro, Jaime
 1960
 2 6 p. 544-547
4 p.
 article
22 First discussion period 1960
 2 6 p. 509-510
2 p.
 article
23 First discussion period 1960
 2 6 p. 622-623
2 p.
 article
24 First morning discussion period 1960
 2 6 p. 563-
1 p.
 article
25 Functional obstruction of the left ventricle, (Acquired aortic subvalvular stenosist) 1960
 2 6 p. 720-721
2 p.
 article
26 Identification of 24-dehydrocholesterol in the serum of patients treated with MER-29 Steinberg, Daniel
 1960
 2 6 p. 586-592
7 p.
 article
27 I. Excretory products of the sterol biosynthetic pathway in the MER-29-treated rat Blohm, Thomas R.
 1960
 2 6 p. 519-523
5 p.
 article
28 Introduction to the proceedings Brust, Albert A.
 1960
 2 6 p. 485-486
2 p.
 article
29 Introductory remarks Wright, Irving S.
 1960
 2 6 p. 487-488
2 p.
 article
30 Mechanism and treatment of A-V heart block and adams-stokes syndrome Bellet, Samuel
 1960
 2 6 p. 691-705
15 p.
 article
31 Metabolic effects of MER-29 Oaks, Wilbur W.
 1960
 2 6 p. 612-617
6 p.
 article
32 Note on MER-29 in arteriosclerotic heart disease Corcoran, A.C.
 1960
 2 6 p. 576-577
2 p.
 article
33 Observations of the effects of MER-29 on serum cholesterol and cholesterol esters Waddell, William R.
 1960
 2 6 p. 597-604
8 p.
 article
34 Observations on the effect of triparanol (MER-29) on the serum cholesterol of selected human subjects Rosenman, Ray H.
 1960
 2 6 p. 605-611
7 p.
 article
35 Prognostic significance of triparanol (MER-29) Lisan, Philip
 1960
 2 6 p. 618-621
4 p.
 article
36 Second discussion period 1960
 2 6 p. 524-
1 p.
 article
37 Second discussion period 1960
 2 6 p. 645-
1 p.
 article
38 Summary of basic science section Bloch, Konrad E.
 1960
 2 6 p. 539-540
2 p.
 article
39 Summary of clinical section I Wilkins, Robert W.
 1960
 2 6 p. 593-596
4 p.
 article
40 Summary of clinical section II Page, Irvine H.
 1960
 2 6 p. 646-648
3 p.
 article
41 The cholesterol lowering effects of triparanol (MER-29) in subjects with and without coronary artery disease Hollander, William
 1960
 2 6 p. 637-644
8 p.
 article
42 The effect of MER-29, a cholesterol synthesis inhibitor, on adrenal function, blood clotting mechanisms, and serum lipids, before and after simulated stress in man Ford, Ralph V.
 1960
 2 6 p. 548-552
5 p.
 article
43 The mechanism of action of MER-29 Avigan, Joel
 1960
 2 6 p. 525-530
6 p.
 article
44 The surgical treatment of persistent ductus arteriosus 1960
 2 6 p. 721-
1 p.
 article
45 The toxicology of MER-29 King, William M.
 1960
 2 6 p. 504-508
5 p.
 article
46 Third discussion period 1960
 2 6 p. 536-538
3 p.
 article
47 Welcoming remarks McMaster, R.H.
 1960
 2 6 p. 487-
1 p.
 article
48 Wolff-parkinson-white syndrome: Historical and clinical features Wolff, Louis
 1960
 2 6 p. 677-690
14 p.
 article
                             48 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands